Scope Fluidics SA

Chart & Performance

D1W1MN

P/E

—

P/S

790.31

EPS

—

Div Yield, %

—

Shrs. gr., 5y

3.32%

Rev. gr., 5y

195.27%

Revenues

516k

+27.72%

Net income

-19m

CFO

-19m

L-32.32%

Dividend

Mar 24, 202385.57 PLN/sh

Profile

Scope Fluidics S.A., a biotechnology company, engages in the designing and developing projects based on microfluidic technologies in medical diagnostics and healthcare. It offers BacterOMIC, an antibiotic susceptibility testing. The company was founded in 2010 and is based in Warsaw, Poland.

URL

https://scopefluidics.com/

IPO date

Aug 16, 2017

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title PLN in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title PLN in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	516 27.72%	404
Cost of revenue	1,888	872
Unusual Expense (Income)
NOPBT	(1,372)	(468)
NOPBT Margin
Operating Taxes	129	69,054
Tax Rate
NOPAT	(1,501)	(69,522)
Net income	(18,785) -105.90%	318,489 -6,388.04%
Dividends	(233,258)
Dividend yield	43.66%
Proceeds from repurchase of equity		4
BB yield		0.00%
Debt
Debt current	873	571
Long-term debt	3,945	4,339
Deferred revenue	3,745	3,689
Other long-term liabilities	8,956	2,660
Net debt	(82,871)	(327,343)
Cash flow
Cash from operating activities	(19,057)	(28,158)
CAPEX	(2,151)	(1,298)
Cash from investing activities	(12,026)	371,126
Cash from financing activities	(234,224)	(30,280)
FCF	(1,505)	(52,527)
Balance
Cash	87,193	331,598
Long term investments	496	655
Excess cash	87,663	332,233
Stockholders' equity	9,459	261,502
Invested Capital	86,581	80,275
ROIC
ROCE
EV
Common stock shares outstanding	2,726	2,699
Price	196.00 -5.54%	207.50 52.13%
Market cap	534,296 -4.59%	559,985 52.83%
EV	451,425	232,642
EBITDA	(292)	196
EV/EBITDA		1,186.95
Interest	329	10,826
Interest/NOPBT